AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13 | +225.0% | 800 | -81.4% | 0.00% | – |
| Q1 2023 | $4 | +33.3% | 4,300 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.7% | 4,300 | +168.8% | 0.00% | – |
| Q3 2022 | $1,000 | -95.8% | 1,600 | -95.9% | 0.00% | -100.0% |
| Q2 2022 | $24,000 | -81.5% | 39,498 | -37.5% | 0.00% | -85.7% |
| Q1 2022 | $130,000 | +364.3% | 63,201 | +1014.9% | 0.01% | +600.0% |
| Q4 2021 | $28,000 | – | 5,669 | +5569.0% | 0.00% | – |
| Q4 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 100 | -98.6% | 0.00% | -100.0% |
| Q2 2020 | $15,000 | -44.4% | 7,300 | -20.7% | 0.00% | -50.0% |
| Q1 2020 | $27,000 | -86.7% | 9,200 | -56.3% | 0.00% | -75.0% |
| Q1 2017 | $203,000 | – | 21,065 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 985,210 | $10,345,000 | 6.10% |
| Broadfin Capital, LLC | 3,568,122 | $37,465,000 | 5.54% |
| JW Asset Management, LLC | 444,439 | $4,667,000 | 3.42% |
| ARMISTICE CAPITAL, LLC | 1,688,000 | $17,724,000 | 2.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $38,383,000 | 1.73% |
| FALCON POINT CAPITAL, LLC | 661,490 | $6,284,000 | 0.91% |
| KNOTT DAVID M | 158,555 | $1,665,000 | 0.71% |
| Perceptive Advisors | 3,098,010 | $32,530,000 | 0.62% |
| Sio Capital Management, LLC | 91,413 | $960,000 | 0.50% |
| HEARTLAND ADVISORS INC | 700,000 | $7,350,000 | 0.48% |